Sartorius Stedim Biotech SA (SDMHF)
247.25
0.00 (0.00%)
USD |
OTCM |
Dec 05, 16:00
Sartorius Stedim Biotech Profit Margin (Quarterly): 9.17% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | 1.67% |
| Innate Pharma SA | -- |
| Inventiva SA | -- |
| Nanobiotix SA | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 6.53% |
| Return on Assets | 3.22% |
| Return on Invested Capital | 3.83% |
| Gross Profit Margin (Quarterly) | 46.39% |
| Operating Margin (Quarterly) | 19.80% |
| Return on Net Operating Assets | 3.56% |